International Scientific Progress in Urology

Objective To analyse the effect of the application of Ning Utai capsule combined with Pazufloxacin on the therapeutic efficacy in the treatment of urinary system infection. Methods: The patients with urinary system infection admitted to our hospital from July 2022 to July 2023 were selected and divided into two groups on average, with a total of 100 cases, i.e., they were divided into the study group of Ning Uitai capsule combined with Pazufloxacin (n=50) and the reference group of Pazufloxacin treatment (n=50), and the statistical results were compared. Results: The clinical effect of the study group after treatment was higher than that of the reference group, the time of symptom improvement and disappearance was shorter than that of the reference group, and the bacteriological changes were better than that of the reference group, and the difference was statistically significant (P＜0.05). Conclusion: The combined use of ningguoitai capsule on the basis of palzhufloxacin in the treatment of urinary system infection can improve the clinical symptoms of patients and promote the therapeutic effect.

Urinary system infection; ningguotai capsule; palzhufloxacin; therapeutic effect